SG11201602661PA - Novel peptide compositions - Google Patents

Novel peptide compositions

Info

Publication number
SG11201602661PA
SG11201602661PA SG11201602661PA SG11201602661PA SG11201602661PA SG 11201602661P A SG11201602661P A SG 11201602661PA SG 11201602661P A SG11201602661P A SG 11201602661PA SG 11201602661P A SG11201602661P A SG 11201602661PA SG 11201602661P A SG11201602661P A SG 11201602661PA
Authority
SG
Singapore
Prior art keywords
novel peptide
peptide compositions
compositions
novel
peptide
Prior art date
Application number
SG11201602661PA
Other languages
English (en)
Inventor
Richard Franklin
Original Assignee
Tarix Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tarix Pharmaceuticals Ltd filed Critical Tarix Pharmaceuticals Ltd
Publication of SG11201602661PA publication Critical patent/SG11201602661PA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
SG11201602661PA 2013-10-11 2014-10-01 Novel peptide compositions SG11201602661PA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361890056P 2013-10-11 2013-10-11
US201461940095P 2014-02-14 2014-02-14
PCT/US2014/058646 WO2015054006A2 (en) 2013-10-11 2014-10-01 Novel peptide compositions

Publications (1)

Publication Number Publication Date
SG11201602661PA true SG11201602661PA (en) 2016-05-30

Family

ID=52813728

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201602661PA SG11201602661PA (en) 2013-10-11 2014-10-01 Novel peptide compositions

Country Status (13)

Country Link
EP (1) EP3054967A4 (https=)
JP (1) JP2017501967A (https=)
KR (1) KR20160065969A (https=)
CN (1) CN105828831A (https=)
AU (1) AU2014332346B2 (https=)
BR (1) BR112016007816A2 (https=)
CA (1) CA2926641A1 (https=)
CL (1) CL2016000836A1 (https=)
IL (1) IL244956B (https=)
MX (1) MX2016004660A (https=)
RU (1) RU2016112931A (https=)
SG (1) SG11201602661PA (https=)
WO (1) WO2015054006A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017150327A1 (ja) * 2016-03-03 2017-09-08 不二製油グループ本社株式会社 神経栄養因子の脳内分泌促進するための食品添加用組成物
WO2018151352A1 (ko) * 2017-02-16 2018-08-23 (주)케어젠 살리실산과 펩타이드의 결합체

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4244946A (en) 1979-06-11 1981-01-13 The Salk Institute For Biological Studies Water-soluble peptides affecting gonadal function
US4305872A (en) 1979-10-19 1981-12-15 Kenneth Wingrove Polypeptide derivatives
US4316891A (en) 1980-06-14 1982-02-23 The Salk Institute For Biological Studies Extended N-terminal somatostatin
US6031072A (en) 1996-07-12 2000-02-29 Mcgill University Compounds and methods for modulating cell adhesion
US20020168761A1 (en) 2000-01-24 2002-11-14 Gour Barbara J. Peptidomimetic modulators of cell adhesion
EP1572887A4 (en) * 2001-08-24 2008-12-24 Neuren Pharmaceuticals Ltd NERVE REGENERATING PEPTIDE AND METHOD FOR THEIR USE IN THE TREATMENT OF A BRAIN DAMAGE
US7563862B2 (en) 2001-08-24 2009-07-21 Neuren Pharmaceuticals Limited Neural regeneration peptides and methods for their use in treatment of brain damage
WO2004058807A2 (en) * 2002-12-24 2004-07-15 Algonomics N.V. Mhc class i restricted t-cell stimulating peptides from hepatitis b virus
JP5026083B2 (ja) * 2003-10-31 2012-09-12 クロンズ ホールディングズ カンパニー リミテッド 神経再生ペプチド及び脳損傷治療におけるそれらの使用方法
WO2007011595A2 (en) * 2005-07-15 2007-01-25 Neuren Pharmaceuticals Limited Neural regeneration peptides and antioxidants protect neurons from degeneration
JP2013532172A (ja) * 2010-07-09 2013-08-15 ダナ ファーバー キャンサー インスティテュート インコーポレイテッド 安定化したインスリン分泌促進ペプチド及び使用方法
KR20140140546A (ko) * 2012-02-10 2014-12-09 타릭스 파마슈티컬스 엘티디. 말초 혈관 질환의 치료를 위한 조성물 및 방법

Also Published As

Publication number Publication date
EP3054967A4 (en) 2017-04-19
CN105828831A (zh) 2016-08-03
AU2014332346A1 (en) 2016-05-05
CA2926641A1 (en) 2015-04-16
RU2016112931A3 (https=) 2018-06-20
RU2016112931A (ru) 2017-11-16
WO2015054006A3 (en) 2015-06-04
WO2015054006A2 (en) 2015-04-16
EP3054967A2 (en) 2016-08-17
AU2014332346B2 (en) 2019-01-24
BR112016007816A2 (pt) 2017-12-05
CL2016000836A1 (es) 2016-09-16
IL244956B (en) 2019-10-31
MX2016004660A (es) 2016-11-14
IL244956A0 (en) 2016-05-31
JP2017501967A (ja) 2017-01-19
KR20160065969A (ko) 2016-06-09

Similar Documents

Publication Publication Date Title
GB201304662D0 (en) Compositions
IL242005B (en) A peptide compound
SG11201602596UA (en) Stabilized efinaconazole compositions
ZA201505966B (en) Peptides and compositions
GB201303771D0 (en) Nanoparticles peptide compositions
GB201608461D0 (en) Compositions
EP3006525A4 (en) ASPHALT-URETHANE COMPOSITION
GB201317105D0 (en) Novel Composition
ZA201505650B (en) New compositions
ZA201504986B (en) Peptide
PT3061771T (pt) Novo péptido unido a quatro epitopos ctl
GB201320962D0 (en) Compositions
ZA201504987B (en) Peptide
GB201316463D0 (en) Novel compositions
GB201319923D0 (en) Novel composition
GB201310513D0 (en) Novel composition
GB201301774D0 (en) Composition
IL244956B (en) New peptide compositions
GB201303787D0 (en) Nanoparticle peptide compositions
GB201320959D0 (en) Compositions
GB201322510D0 (en) Novel composition
GB201316464D0 (en) Novel compositions
GB201315598D0 (en) Novel compositions
GB201312224D0 (en) Compositions
GB201304927D0 (en) Compositions